Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge
- 9 April 2004
- Vol. 22 (25-26), 3358-3366
- https://doi.org/10.1016/j.vaccine.2004.02.034
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Monkeypox Outbreak a Reminder of Emerging Infections VulnerabilitiesJAMA, 2003
- Diagnosis and Management of SmallpoxNew England Journal of Medicine, 2002
- Transmission potential of smallpox in contemporary populationsNature, 2001
- Modeling Potential Responses to Smallpox as a Bioterrorist WeaponEmerging Infectious Diseases, 2001
- Smallpox as a Biological WeaponJAMA, 1999
- Neutralizing and Protective Antibodies Directed against Vaccinia Virus Envelope AntigensVirology, 1999
- Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelopeProceedings of the National Academy of Sciences, 1998
- Viral Vaccines and Antivirals: Current Use and Future ProspectsAnnual Review of Public Health, 1988
- FOUR GENERATIONS OF PROBABLE PERSON-TO-PERSON TRANSMISSION OF HUMAN MONKEYPOXAmerican Journal of Epidemiology, 1986
- Significance of Extracellular Enveloped Virus in the in vitro and in vivo Dissemination of VacciniaJournal of General Virology, 1980